Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Asian Stocks Mixed With Doubts Cast on Moderna Vaccine Results

Published 05/19/2020, 11:25 PM
Updated 05/19/2020, 11:34 PM
© Reuters.

By Gina Lee

Investing.com – Asian stocks were mixed on Wednesday morning, retreating from their gains on Tuesday.

Investors digested a report from several vaccine experts that said that U.S. drug maker Moderna (NASDAQ:MRNA) provided insufficient information to determine how effective its potential vaccine for the COVID-19 virus actually is.

Moderna’s Monday announcement that its vaccine appeared to be generating an immune response in all its 45 trial participants, boosted stocks on Tuesday. But the experts warned that the announcement should be taken “with a big grain of salt.”

Meanwhile, China’s central bank left both the 1-year loan prime rate and the 5-year loan prime rate unchanged at 3.85%, and 4.65% respectively.

China’s Shanghai Composite was down 0.45% and the Shenzhen Component was down 0.37% by 11:37 PM ET (4:37 AM GMT), with U.S.-China tensions continuing to simmer in the background.

The country's National People’s Congress will kick off on Friday after a two-month delay due to COVID-19.

Hong Kong’s Hang Seng Index was down 0.12%, giving up some of its earlier gains, and Japan’s Nikkei 225 rose 0.96%. 

The Reuters Tankan survey showed that Japanese business confidence hit decade lows in May, with firms bracing for a protracted period of economic turmoil due to COVID-19.

South Korea’s KOSPI gained 0.21%, even with the country struggling to contain its second wave of cases originating in nightclubs around Seoul’s Itaewon neighborhood. 32 new cases were reported on Tuesday, the most since May 11, and brings the total number of cases in the country to 11,110.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

But Korean high school seniors returned to their classrooms today as schools started a reopening program in stages.

Down Under, the ASX 200 rose 0.06%, slowly reversing its earlier losses.

As Moderna's announcement damped investor sentiment, some investors cautiously held onto the small hope of an economic recovery.

“We are being fairly cautious,” Shawn Matthews, founder and chief investment officer at Hondius Capital Management LP, told Bloomberg.

But he added, “If you look at the economy, it feels like it’s the summer of hope right now, where everyone is hoping it’s going to turn around.”

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.